Wolzt M - Search Results

1

Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion.

Pleiner J, Schaller G, Mittermayer F, Marsik C, MacAllister RJ, Kapiotis S, Ziegler S, Ferlitsch A, Wolzt M. Pleiner J, et al. Among authors: wolzt m. Atherosclerosis. 2008 Mar;197(1):383-91. doi: 10.1016/j.atherosclerosis.2007.06.011. Epub 2007 Jul 23. Atherosclerosis. 2008. PMID: 17645881 Clinical Trial.

2

Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo.

Krejcy K, Eichler HG, Jilma B, Kapiotis S, Wolzt M, Zanaschka G, Gasic S, Schütz W, Wagner O. Krejcy K, et al. Among authors: wolzt m. Can J Physiol Pharmacol. 1996 Jan;74(1):9-14. Can J Physiol Pharmacol. 1996. PMID: 8963958 Clinical Trial.

3

Nitric oxide and ocular blood flow in patients with IDDM.

Schmetterer L, Findl O, Fasching P, Ferber W, Strenn K, Breiteneder H, Adam H, Eichler HG, Wolzt M. Schmetterer L, et al. Among authors: wolzt m. Diabetes. 1997 Apr;46(4):653-8. doi: 10.2337/diab.46.4.653. Diabetes. 1997. PMID: 9075807 Clinical Trial.

4

Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine.

Wolzt M, Schmetterer L, Ferber W, Artner E, Mensik C, Eichler HG, Krejcy K. Wolzt M, et al. Am J Physiol. 1997 Feb;272(2 Pt 2):F178-82. doi: 10.1152/ajprenal.1997.272.2.F178. Am J Physiol. 1997. PMID: 9124393

5

Hemodynamic effects of parathyroid hormone-related peptide-(1-34) in humans.

Wolzt M, Schmetterer L, Dorner G, Zelger G, Entlicher J, Kapiotis S, Eichler HG. Wolzt M, et al. J Clin Endocrinol Metab. 1997 Aug;82(8):2548-51. doi: 10.1210/jcem.82.8.4120. J Clin Endocrinol Metab. 1997. PMID: 9253332 Clinical Trial.

6

Role of nitric oxide in exercise-induced vasodilation in man.

Koller-Strametz J, Matulla B, Wolzt M, Müller M, Entlicher J, Eichler HG, Schmetterer L. Koller-Strametz J, et al. Among authors: wolzt m. Life Sci. 1998;62(11):1035-42. doi: 10.1016/s0024-3205(98)00024-1. Life Sci. 1998. PMID: 9515561 Clinical Trial.

7

Biochemical characterization of S-nitrosohemoglobin. Mechanisms underlying synthesis, no release, and biological activity.

Wolzt M, MacAllister RJ, Davis D, Feelisch M, Moncada S, Vallance P, Hobbs AJ. Wolzt M, et al. J Biol Chem. 1999 Oct 8;274(41):28983-90. doi: 10.1074/jbc.274.41.28983. J Biol Chem. 1999. PMID: 10506146 Free article.

8

Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humans.

Bayerle-Eder M, Wolzt M, Polska E, Langenberger H, Pleiner J, Teherani D, Rainer G, Polak K, Eichler HG, Schmetterer L. Bayerle-Eder M, et al. Among authors: wolzt m. Am J Physiol Regul Integr Comp Physiol. 2000 Jun;278(6):R1667-73. doi: 10.1152/ajpregu.2000.278.6.R1667. Am J Physiol Regul Integr Comp Physiol. 2000. PMID: 10848537 Free article. Clinical Trial.

9

Glucose and insulin exert additive ocular and renal vasodilator effects on healthy humans.

Luksch A, Polak K, Matulla B, Dallinger S, Kapiotis S, Rainer G, Wolzt M, Schmetterer L. Luksch A, et al. Among authors: wolzt m. Diabetologia. 2001 Jan;44(1):95-103. doi: 10.1007/s001250051585. Diabetologia. 2001. PMID: 11206417 Clinical Trial.

10

Train your endothelium.

Pleiner J, Wolzt M. Pleiner J, et al. Among authors: wolzt m. Wien Klin Wochenschr. 2001 Sep 17;113(17-18):635-7. Wien Klin Wochenschr. 2001. PMID: 11603096 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters